These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38955788)

  • 1. Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review.
    Maguire PA; Bastiampillai T; Allison S; Wilkes F; Looi JCL
    East Asian Arch Psychiatry; 2024 Jun; 34(2):29-36. PubMed ID: 38955788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivastigmine as an effective add-on to standard treatment of veterans with chronic posttraumatic stress disorder: a case series.
    Fayyazi Bordbar MR; Talaei A
    J Clin Psychopharmacol; 2013 Oct; 33(5):706-9. PubMed ID: 23948788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial.
    Rezaei Ardani A; Hosseini G; Fayyazi Bordbar MR; Talaei A; Mostafavi Toroghi H
    J Clin Psychopharmacol; 2017 Feb; 37(1):54-60. PubMed ID: 27930500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms.
    Bertolini F; Robertson L; Bisson JI; Meader N; Churchill R; Ostuzzi G; Stein DJ; Williams T; Barbui C
    Cochrane Database Syst Rev; 2024 May; 5(5):CD013613. PubMed ID: 38767196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-deployment programmes for building resilience in military and frontline emergency service personnel.
    Doody CB; Robertson L; Cox KM; Bogue J; Egan J; Sarma KM
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013242. PubMed ID: 34870330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple session early psychological interventions for the prevention of post-traumatic stress disorder.
    Roberts NP; Kitchiner NJ; Kenardy J; Robertson L; Lewis C; Bisson JI
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD006869. PubMed ID: 31425615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.
    Coventry PA; Meader N; Melton H; Temple M; Dale H; Wright K; Cloitre M; Karatzias T; Bisson J; Roberts NP; Brown JVE; Barbui C; Churchill R; Lovell K; McMillan D; Gilbody S
    PLoS Med; 2020 Aug; 17(8):e1003262. PubMed ID: 32813696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
    Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
    Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.
    Andrus MR; Gilbert E
    Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
    Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine for Alzheimer's disease.
    Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults.
    Brown R; Cherian K; Jones K; Wickham R; Gomez R; Sahlem G
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015040. PubMed ID: 39092744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibitors for Alzheimer's disease.
    Birks J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD005593. PubMed ID: 16437532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.